Ginkgo bioworks announces collaboration with merck to improve biologic manufacturing

Boston , aug. 7, 2023 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration with merck, known as msd outside of the united states and canada, focused on improving biologic manufacturing. ginkgo will apply its expertise and capabilities in cell engineering, ultra high-throughput multiplexed screening, protein characterization and process optimization to improve production efficiency and increase yields.
DNA Ratings Summary
DNA Quant Ranking